Thesis (M.Sc.(Agric, Science and Technology) North-West University, Mafikeng Campus, 2012

In High Dose Rate (HDR) brachytherapy, treatment dose to patients is highly dependent on the accuracy of positioning and duration of the source. Source misplacement or wrong duration of treatment could potentially result in adverse clinical side effects to patients. In order to maintain successful treatment for patients, an independent Quality Assurance (QA) verification is crucial to measure the High Dose Rate (HDR) source positioning and dwell time periodically to ensure the prescribed dose is correct and safe for brachytherapy treatment. The current QA practice used to validate the accuracy of dwell time of the source is by using a stopwatch and measure the dwell position on the source position check ruler. Nevertheless, reaction time of human poses a major concern regarding the accuracy in these manual operating procedures. In this thesis, a new QA tool is proposed to acquire accurate information about time structure and source positioning in HDR brachytherapy. The tool consists of a consumer-grade webcam, a source position check ruler, a laptop computer and a custom-made combined camera-ruler mounting tool. The camera is used to capture the motion of the moving source in real time. Each frame contains positional and temporal information that are important to determine the difference between the measured and the actual HDR source position and time structure. Finally, a Graphical User Interface (GUI) application program is developed to receive the input from the camera for image processing. The measured results (time structure and positional information) are displayed on the computer screen as the output of the designed application. The tool was found to be able to reduce the time required significantly for the QA and minimize the impact of human errors. At the time of writing, the sensitivity of the system to luminous changes in the environment warrants further efforts to render the tool even more useful. Based on the experimental results, the accuracy of dwell time measured by the proposed system was ± 40 ms. The minimum detectable dwell time of the proposed system was 200 ms. The range of effective dwell position that could be measured by the system ranged from 1300 mm to 1500 mm (excluding 1300 mm and 1500 mm). The accuracy of dwell position measured by the proposed system was ± 1mm. / published_or_final_version / Diagnostic Radiology / Master / Master of Medical Sciences

No description available.

Thesis (Ph. D.)--University of Wisconsin--Madison, 1981. / Typescript. Vita. eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references (leaves 122-127).

No description available.

No description available.

No description available.

"Modern medical therapies involving radioisotopes provide radionuclide contamination in wastewater. These radioisotopes present in wastewater increase the possibility of human exposure to radiation. The objective of this work was to study the fate of radionuclides of medical sources in wastewater, and to determine the distribution of various radionuclides in different stages of wastewater treatment. Influent, return activated sludge and effluent samples were collected from four wastewater facilities in Massachusetts. Samples were collected approximately twice a month over 4 months. The radionuclides and their decay products were tested by inductively coupled plasma with mass spectrometry (ICP-MS) and broad energy germanium detector analysis (BEGe). The samples were analyzed to determine the content and radioactivity of each target radionuclide and decay product for three treatment stages (influent, return activated sludge and effluent) from each facility at different sampling times. The results indicated that I-131 is the only radionuclide in wastewater, however many decay products were identified. Recommendations are put forward according to the testing results."

Radiation dosimetry is necessary for optimising radiation-based medical procedures for individual patients but in the field of nuclear medicine there are few widely available or widely used tools for performing this kind of analysis. Those tools that are available tend to focus on one particular component of the dosimetry problem and integrating tools to form a complete system is left to the end-user. A software system for performing individual, image-based dosimetry analysis of nuclear medicine studies has been developed and validated. The system consists of a suite of tools that use common file formats and data models. The tools can be integrated to form applications by means of a simple scripting system. One tool is a gamma camera simulator that can produce realistic images of dynamic activity distributions in planar or tomographic formats. Simulated imaging studies produced by this tool are used to validate the other tools in the system. In addition, the system implements a method of simulation assisted quantitation which is shown to achieve high accuracy in both software and physical phantom studies. The system is applied to the dosimetry of I-131 Lipiodol, a therapeutic agent used to treat primary and secondary cancers of the liver. Simulation studies are used to validate the analytic methods used. Studies of a series of patients, treated over a period 10 years, are retrospectively analysed using a selection of methods appropriate to the available data. The results of the analysis demonstrated a large range of lung doses from 1 to 10 Gy/GBq administered. The median absorbed dose in liver was 3 Gy (range 1 - 10 Gy) and the median absorbed dose in tumor was 19 Gy (range 5 - 84 Gy). The large individual variation reinforces the necessity of individualised dosimetry for treatment planning and follow up.

Radiation dosimetry is necessary for optimising radiation-based medical procedures for individual patients but in the field of nuclear medicine there are few widely available or widely used tools for performing this kind of analysis. Those tools that are available tend to focus on one particular component of the dosimetry problem and integrating tools to form a complete system is left to the end-user. A software system for performing individual, image-based dosimetry analysis of nuclear medicine studies has been developed and validated. The system consists of a suite of tools that use common file formats and data models. The tools can be integrated to form applications by means of a simple scripting system. One tool is a gamma camera simulator that can produce realistic images of dynamic activity distributions in planar or tomographic formats. Simulated imaging studies produced by this tool are used to validate the other tools in the system. In addition, the system implements a method of simulation assisted quantitation which is shown to achieve high accuracy in both software and physical phantom studies. The system is applied to the dosimetry of I-131 Lipiodol, a therapeutic agent used to treat primary and secondary cancers of the liver. Simulation studies are used to validate the analytic methods used. Studies of a series of patients, treated over a period 10 years, are retrospectively analysed using a selection of methods appropriate to the available data. The results of the analysis demonstrated a large range of lung doses from 1 to 10 Gy/GBq administered. The median absorbed dose in liver was 3 Gy (range 1 - 10 Gy) and the median absorbed dose in tumor was 19 Gy (range 5 - 84 Gy). The large individual variation reinforces the necessity of individualised dosimetry for treatment planning and follow up.